KKR Real Estate Finance Trust’s Q3 results highlight ongoing portfolio challenges, with life sciences exposure continuing to ...
Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback